South San Francisco, CA, United States of America

Shoko Kawana

This inventor holds 2 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignee: Second Genome, Inc.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shoko Kawana. Retrieved from https://idiyas.com/inventor/shoko-kawana

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Shoko Kawana: Innovator in Biotherapeutics

Introduction

Shoko Kawana is a notable inventor based in South San Francisco, CA (US). He has made significant contributions to the field of biotherapeutics, particularly in the development of live biotherapeutic products and probiotics. With a total of 2 patents, his work focuses on innovative solutions for treating various human diseases.

Latest Patents

Kawana's latest patents revolve around live biotherapeutic products and their applications. The disclosures relate to probiotics and pharmaceutical compositions that utilize these probiotics to address human health issues. Specifically, his inventions provide compositions comprising strains of bacteria that are effective in treating metabolic-related diseases or disorders.

Career Highlights

Shoko Kawana is currently associated with Second Genome, Inc., where he continues to advance research in biotherapeutics. His expertise in the field has positioned him as a key player in developing innovative treatments that leverage the power of probiotics.

Collaborations

Kawana collaborates with talented individuals such as Andrew Wonhee Han and Bernat Baeza Raja, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Shoko Kawana's work in biotherapeutics exemplifies the impact of innovation in healthcare. His patents and ongoing research are paving the way for new treatments that could significantly improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…